Aspira Pathlab & Diagnostics Ltd — Updates, 16-05-2025: Company Update

Aspira Pathlab & Diagnostics has announced a board meeting to approve the re-appointment of Dr. Pankaj Shah as Managing Director & CEO for three years from August 1, 2025, to July 31, 2028, subject to shareholder approval. Dr. Shah brings over 43 years of pathology experience, including medical and specialized training, and has been a consulting pathologist for 40 years. He is not related to any other director or key managerial personnel, and there are no restrictions on him holding the office. This continuity in leadership supports the company’s operational stability and strategic direction.